BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37272472)

  • 1. Cidofovir for Viral Infections in Immunocompromised Children: Guidance on Dosing, Safety, Efficacy, and a Review of the Literature.
    Riggsbee DL; Alali M; Kussin ML
    Ann Pharmacother; 2024 Mar; 58(3):286-304. PubMed ID: 37272472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Cidofovir Treatment for Suspected or Confirmed Adenovirus Infection in Immunocompetent Pediatric Population.
    Zalcman J; Pasternak Y; Kenan D; Dotan M; Gueta I; Kadmon G; Peled O; Bilavsky-Yarden H
    Pediatr Infect Dis J; 2024 Mar; 43(3):198-202. PubMed ID: 38011019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
    Kwon HJ; Kang JH; Lee JW; Chung NG; Kim HK; Cho B
    Transpl Infect Dis; 2013 Dec; 15(6):569-74. PubMed ID: 24028353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation.
    Lee SS; Ahn JS; Jung SH; Ahn SY; Kim JY; Jang HC; Kang SJ; Jang MO; Yang DH; Kim YK; Lee JJ; Kim HJ
    Korean J Intern Med; 2015 Mar; 30(2):212-8. PubMed ID: 25750563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Toxicity in Pediatric Patients Receiving Cidofovir for the Treatment of Adenovirus Infection.
    Vora SB; Brothers AW; Englund JA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):399-402. PubMed ID: 28419263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
    Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
    Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.
    Carter BA; Karpen SJ; Quiros-Tejeira RE; Chang IF; Clark BS; Demmler GJ; Heslop HE; Scott JD; Seu P; Goss JA
    Transplantation; 2002 Oct; 74(7):1050-2. PubMed ID: 12394854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir in the treatment of cytomegaloviral disease.
    Kendle JB; Fan-Havard P
    Ann Pharmacother; 1998 Nov; 32(11):1181-92. PubMed ID: 9825085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
    Momper JD; Zhao Y; Shapiro R; Schonder KS; Gao Y; Randhawa PS; Venkataramanan R
    Transpl Infect Dis; 2013 Feb; 15(1):34-41. PubMed ID: 23025519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue.
    Lalezari JP; Drew WL; Glutzer E; James C; Miner D; Flaherty J; Fisher PE; Cundy K; Hannigan J; Martin JC
    J Infect Dis; 1995 Apr; 171(4):788-96. PubMed ID: 7706804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BK virus encephalitis: case report, review of the literature, and description of a novel treatment modality.
    Chittick P; Williamson JC; Ohl CA
    Ann Pharmacother; 2013 Sep; 47(9):1229-33. PubMed ID: 24259742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Philippe M; Ranchon F; Gilis L; Schwiertz V; Vantard N; Ader F; Labussiere-Wallet H; Thomas X; Nicolini FE; Wattel E; Ducastelle-Leprêtre S; Barraco F; Lebras L; Salles G; Michallet M; Rioufol C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):723-730. PubMed ID: 26718666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
    J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
    Caruso Brown AE; Cohen MN; Tong S; Braverman RS; Rooney JF; Giller R; Levin MJ
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3718-25. PubMed ID: 25733509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cidofovir: a new therapy for cytomegalovirus retinitis.
    Lalezari JP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S22-6. PubMed ID: 9058614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
    Platzbecker U; Bandt D; Thiede C; Helwig A; Freiberg-Richter J; Schuler U; Plettig R; Geissler G; Rethwilm A; Ehninger G; Bornhäuser M
    Transplantation; 2001 Apr; 71(7):880-5. PubMed ID: 11349720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
    Wolf DL; Rodríguez CA; Mucci M; Ingrosso A; Duncan BA; Nickens DJ
    J Clin Pharmacol; 2003 Jan; 43(1):43-51. PubMed ID: 12520627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.